IN THE NEWS
- http://www.uwhealth.org/pat-feeds/Feed.action?type=news&format=title&rows=5&sort=date&displaySites=smph&tagged=wimr&callback=?
With an emphasis on cancer research, the Wisconsin Institutes for Medical Research (WIMR) at the University of Wisconsin School of Medicine and Public Health in Madison is designed to allow researchers to work with scientists from other disciplines, speeding the transfer of science to the people who will benefit from it.
Learn More About the Wisconsin Institutes for Medical Research
Collaboration Advances Care
The Wisconsin Institutes for Medical Research builds on the UW School of Medicine and Public Health's tradition of collaborative research. In the video at left, Dr. Richard Moss, senior associate dean for basic research, biotechnology and graduate studies, explains how collaboration with clinical faculty has played a key role in his research. Read a Q&A with Moss to learn more about WIMR. |
 |
Inspiration. Discovery. Hope.Designed to enhance the collaboration of researchers in both the clinical and basic sciences, the Wisconsin Institutes for Medical Research will eventually grow to three towers dedicated to moving new discoveries from laboratory to bedside and into communities.
Your gift our efforts to improve the health of Wisconsin's citizens by unlocking the mysteries of disease through research and discovery.
|
 |
Environment of Discovery
In concept, design and actuality, the Wisconsin Institutes for Medical Research (WIMR) is achieving the goals that school leaders had in mind for it. The state-of-the-art facilities, open laboratory design and limited boundaries afford occupants - from the most basic researchers to physicians who conduct research and also see patients - the opportunity to work in close physical proximity. This has proved true for scientists such as Jamey Weichert.
|
 |
The Story Continues to Take Shape
The second tower of the Wisconsin Institutes for Medical Research, scheduled for completion in 2013, will have seven floors devoted to discovery.
The second tower will feature research dedicated to heart and vascular disease, Parkinson's and Alzheimer's diseases, vision, cell and regenerative biology and cancer.
|
|
|
|
